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Abstract. More than 50 mutations in the human hypoxan-  
thine-guanine phosphoribosyltransferase (HPRT) locus 
have been described, yet  only 2 alter the AUG initiation 
codon. One, variant HPRTI151, results in Lesch-Nyhan 
syndrome (LNS), and the other, HPRTnlinoi s, results in par- 
tial HPRT deficiency. Al though previously undetectable, 
we used a sensitive gel assay to demonstrate that HPRTnt_ 
~no~s is not only active, but has a native Mr  indistinguish- 
able f rom normal. Confi rmatory evidence of  activity and 
native Mr is demonstrated fol lowing transfection o f  
HPRT cells with expression plasmids containing c D N A  
sequences representing HPRT[ltinois. These data provide 
support for the hypothesis  that patient RT, or variant 
HPRTnlino~ s, is spared manifestations o f  the LNS as a result 
of  translation at the newly formed G U G  initiation codon. 
Among  individuals phenotypically characterized with 
severe KSS is patient RT, or HPRT variant HPRTminois. 
Genetic analysis of  the HPRT c D N A  from RT identified 
a 13 base pair (bp) deletion within the first exon (Gibbs et 
al. 1989). This deletion spans nucleotides - 1 2  to +1 and 
results in the juxtaposition of  a G to the remaining UG of  
the initiation codon. The consequence o f  this is the re- 
placement o f  the A U G  start codon with a G U G  codon. 
Thus, the approximately 1% of  residual activity in RT 
may be the result o f  either alternative initiation codon us- 
age, or initiation at a downstream, in frame, AUG.  We 
provide evidence in this report that translation of  HPRTII 1 
ino~s m R N A  occurs by inefficient translational initiation at 
the GUG codon formed as a result of  the 13-bp deletion 
and ablation of  the normal A U G  start codon. 
Introduction 
Hypoxanthine-guanine  phosphoribosyltransferase (HPRT; 
EC 2.4.2.8) is a purine salvage enzyme that catalyzes the 
convers ion of  hypoxanthine  and guanine to inosine 
monophosphate  and guanosine monophosphate ,  respec- 
tively. Complete  deficiency of  HPRT enzyme activity 
(< 0.1%) is phenotypical ly  expressed as the Lesch-Nyhan 
syndrome (LNS) and is characterized by choreoathetosis, 
spasticity, and, in many cases, a tendency to self mutila- 
tion by biting o f  the fingers and lips (Lesch and Nyhan 
1964). Partial deficiency, or the Kelley-Seegmiller  syn- 
drome (KSS), is characterized by hyperuricemia,  preco- 
cious gout, and uric acid nephrolithiasis (Kelley et al. 
1972). The genetic abnormalities responsible for these 
HPRT deficiency states have been defined and represent 
a heterogeneous group of  missense and nonsense point 
mutations, deletions, insertions, and other genomic re- 
arrangements (Gibbs et al. 1989; Davidson et al. 1989b; 
Rossiter et al. 1991). 
Correspondence to: B. L. Davidson, Department of Internal Med- 
icine, University of Michigan, 1150 West Medical Center Drive, 
5520 Medical Science Research Building I, Box 0680, Ann Arbor, 
MI 48109-0680, USA 
Materials and methods 
Cell lines and preparation of lysates 
The mutations of the HPRT gene that characterize WE and RT 
(HPRTminoi~) have previously been described (Gibbs et al. 1989). 
B-lymphoblast cell lines from WE and RT were produced by trans- 
formation with Epstein-Barr virus and maintained in RPMI media 
containing 10% fetal calf serum and 2 mM glutamine (Wilson et 
al. 1982). Cell line WE contains no detectable HPRT mRNA by 
RNA blot analysis or RNase A mapping experiments (Wilson et al. 
1986). B-lymphoblast cell line N333 was derived from a normal 
human male (Human Mutant Cell Repository, Camden, N.J.). Cell 
lysates were prepared as previously described and concentrated by 
ultrafiltration (Centricon 10, Amicon). Protein concentrations were 
determined by the method of Lowry (BCA Protein Assay Reagent, 
Pierce). 
Western blot analysis 
Western blot analysis or RT cells lysates for HPRT immunoreac- 
tive material were performed using standard methods (Wilson et 
al. 1982). Increasing amounts of total protein from RT lymphoblast 
cell lysates and known amounts of partially purified human ery- 
throcyte HPRT were subjected to electrophoresis in parallel on 
12% polyacrylamide gels containing 1% sodium dodecyl sulfate 
(SDS). Protein was transferred to PVDF paper (Millipore) using a 
semi-dry blotter apparatus (Biorad). The membrane was blocked 
by incubation with 1% nonfat dry milk in TBS/Tween-20 (0.02 M 
301 
Fig. 1. Western blot analysis of whole cell lysates obtained from 
RT lymphoblasts for HPRT immunoreactive material. Increasing 
amounts of whole cell lysates from RT lymphoblasts were loaded 
onto a 12% polyacrylamide gel containing SDS, subjected to elec- 
trophoresis and transferred to PVDF membrane (Millipore). The 
membrane was blocked for 2 h with TBS/Tween-20 (0.02 M Tris, 
0.5 M NaC1, 0.05% Tween-20, pH7.5) containing 1% bovine 
serum albumin. The membrane was treated with rabbit anti-human 
HPRT antibody for approximately 16 h. After four washes in 
TBS/Tween-20 the membrane was treated with goat anti-rabbit an- 
tibody conjugated to alkaline phosphatase (Bio-Rad), washed, and 
reacted with BCIP/NBT reagents (Gibco BRL). Lanes 1-3 show 
increasing amounts of purified human erythrocyte HPRT: lane 1 
20 ng; lane 2 50 ng; lane 3 200 ng. Lanes 4-6 show increasing 
amounts of RT lymphoblast lysates: lane 4 50/ag; lane 5 100 I.tg; 
lane 6 200 ~g. Lane 7 pre-stained 30-kDa molecular weight mark- 
ers (Amersham). Arrow indicates the location of human HPRT 
protein 
Tris, 0.5 M NaC1.0.05% Tween-20, pH7.5), then incubated for 4 h 
with rabbit anti-human HPRT antibody (diluted 1:20), and washed 
four times in TBS/Tween-20. The membrane was then incubated 
with goat anti-rabbit antibody (diluted 1:100) conjugated to alka- 
line phosphatase (Kirkegaard), washed in TBS/Tween-20, and re- 
acted with BCIP/NBT reagents (Gibco BRL). 
Enzyme activity analysis 
Cell lysates were fractionated by nondenaturing 6% polyacry- 
lamide gel electrophoresis (PAGE), and enzyme activity assayed 
directly as previously described with the following modifications 
(Davidson et al. 1989a). Briefly, the gels were reacted with a mix- 
ture containing 1 mM [8-14C] hypoxanthine (NEN; 57 mCi/ 
mmol), 15 mM PP-ribose-P, and 30 mM MgC1, for 2 h at 37~ 
washed, and exposed to Kodak XAR5 film. The amounts of IMP 
produced during the in situ assays were determined directly from 
the gels by quantification of particle emission using an array de- 
tector (Betagen), and the amount of HPRT activity present was 
quantified as a function of levels of substrate turnover and were 
expressed as cpm [8J4C] IMP/gg of whole cell protein. 
Preparation and amplification of  HPRT cDNAs 
Total cellular RNA was isolated from 1 x 106 RT lymphoblasts or 
1 x 10 6 normal lymphoblasts and amplified as previously described 
(Davidson et al. 1989b). Polymerase chain reaction (PCR) primers 
HP3E and HP5E were used to amplify both normal HPRT and 
HPRTminois cDNAs. The sequence of the 3" primer (HP3E) is 
5"CCG GCG AATTCA GAT GTT TCC AAA CTC AAC TrG3", 
while the sequence of the 5" primer (HP5E) is 5"CCG GCG AAT 
TCC TGA GCA GTC AGC CCG CGC GCC3". Each primer has 
11 bp of flanking sequence within which is an EcoRI site (italics) 
in sequence to facilitate subcloning. Primer HP5E anneals to nu- 
cleotides -37---)-14 of the antisense strand, while HP3E anneals to 
nucleotides +690 ---~ +668 of the sense strand. The resulting partial 
length HPRT cDNA fragment contains the entire protein coding 
region. PCR amplification conditions were denaturation at 94~ 
for 1 min followed by extension at 72~ for 3 min. 
Construction of  expression plasmids 
and transfection into HPRT-deficient cell line WE 
PCR fragments were digested with EcoRI, purified, and cloned 
into the eukaryotic expression vector pSG5 (Stratagene). Recom- 
binant clones were identified by restriction enzyme mapping and 
nucleotide sequencing of plasmid minipreps using standard meth- 
ods (Sambrook et al. 1989). 
WE lymphoblasts were used for all plasmid transfections. Ap- 
proximately 1 x 108 WE lymphoblasts were transfected with 50 gg 
of pSG5HPRT in DEAE dextran in T250 Falcon tissue culture 
flasks (Ausubel et al. 1990). For pSG5HPRTnlinoi s 3 • 10 s WE lym- 
phoblasts were transfected with 150 tag of plasmid in 3 T250 
flasks. Untransfected WE and N333 (normal) lymphoblasts served 
as controls. Cell lysates were isolated 48 h after transfection, con- 
centrated, and assayed for HPRT activity in situ following nonde- 
naturing PAGE. 
Results and discussion 
To address the discrepancy between the severe systemic 
deficiency of HPRT activity and the clinical manifesta-  
tions in patient RT, we attempted to define the relationship 
between the mutan t  genotype and phenotype.  Using rabbit  
po lyc lona l  ant isera  to h u m a n  H P R T  we were able to 
detect small  amounts  of immunoreac t ive  material  present  
in pooled cell lysates obtained from RT lymphoblas ts  
(Fig. 1). Additionally,  HPRTminois comigrates with purif ied 
normal  HPRT providing evidence that the two proteins 
have similar apparent molecular  weights (subunit  Mr). 
Previously, HPRT activity in B- lymphoblas t  lysates ob- 
tained from patient  RT was undetectable by rout ine ra- 
dioisotopic assay on unconcentra ted cell lysates (Wilson 
et al. 1986). However,  by using a more sensit ive radio- 
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Fig.2. HPRT enzyme activity and electrophoretic mobility of 
membrane-tree extracts from normal lymphoblasts and lym- 
phoblasts derived from patient RT. Protein from cell extracts sub- 
jected to electrophoresis through a 6% nondenaturing polyacry- 
lamide gel and assayed in situ for HPRT activity as described. 
Lane 1 normal lymphoblast (N333) lysate (106.9 cpm[8-14C] 
IMP/btg whole cell protein); lane 2 RT lymphoblast lysate (0.37 
cpm [8-~4C] IMP/btg whole cell protein) 
chemical in situ gel assay we were able to detect HPRT 
enzymatic activity present in RT lymphoblast lysates. As 
is evident in Fig. 2, HPRTnlinoi s is capable of  catalyzing 
substrate turnover. The HPRT activity present in the 
lysates was expressed as a function of substrate turnover. 
Enzyme activity of  HPRT~llinoi~ was 0.37 cpm[8-14C] 
IMP/btg whole cell protein, representing 0.34% of control 
values (activity in normal lymphoblasts was 106.9 
cpm [8J4C] IMP/t.tg whole cell protein). This correlates 
closely with the 0.8% level of  immunoreactive protein 
previosly reported (Wilson et al. 1986). Notably, the mi- 
gration of HPRT~11inois and normal HPRT are indistinguish- 
able under nondenaturing conditions. 
To further establish that the 13 bp deletion and resultant 
initiation codon mutation is capable of  promoting transla- 
tion of a functional HPRT, the cDNAs representing nor- 
mal and HPRT1Hinoi~ were cloned into an expression plas- 
mid and the normal and mutant sequences were confirmed 
by nucleotide sequencing. Both pSG5HPRT and 
pSG5HPRTminois were then transfected into the HPRT 
mRNA negative lymphoblast cell line WE and examined 
using a transient expression assay. After transfection the 
cells were harvested, and HPRT activity assessed by in 
situ activity gel of  whole cell lysates. The results of  this 
experiment are shown in Fig. 3. WE cells transfected with 
pSG5HPRT or pSG5HPRTI11i,oi~ expressed HPRT protein 
with a migration pattern indistinguishable from HPRT 
present in normal lymphoblasts. The amount of  HPRT ac- 
tivity present in the pSG5HPRTnlinoi s transfectants when 
expressed as a function of  substrate turnover per micro- 
gram total protein, was 1.6% of the activity present in 
cells transfected with pSG5HPRT. 
Fig.3. Enzymatic activity and native electrophoretic mobility of 
expressed HPRT in HPRT mRNA negative WE lymphoblasts tran- 
siently transfected with pSG5HPRTnlinoi ~ or pSG5HPRT. Mem- 
brane-free cell extracts from transfected WE cells were subjected 
to electrophoresis through a 6% nondenaturing polyacrylamide gel 
and assayed in situ for HPRT activity as described. Cpm were de- 
termined using a Betagen. Lane 1 WE lymphoblasts transfected 
with pSG5HPRTminois (4.9 x 10 3 cpm [8-14C] IMP/~Ig whole cell 
protein; lane 2 WE lymphoblasts transfected with pSG5HPRT 
(0.30 cpm[8-14C] IMP/big whole cell protein); lane 3 WE lym- 
phoblasts as a negative control (no detectable cpm). Note the sim- 
ilar migration pattern of HPRT in both pSG5HPRTminois and 
pSG5HPRT transfected cells 
Definitive verification of the translation initiation site 
used by HPRTi11inois mRNA would require that purified 
preparations of  the HPRTminois protein be subjected to 
peptide sequence analysis (Prats et al. 1989). Because cul- 
tured RT lymphoblasts produce extremely low levels of  
mutant HPRT protein, we were unable to directly isolate 
sufficient amounts of  purified HPRTnlinoi s protein for un- 
ambiguous peptide sequence analysis using either poly- 
clonal rabbit antisera, or by the use of  GMP agarose col- 
umn chromatography. Attempts to isolate stable transfec- 
rants in WE lymphoblasts transfected with pSG5HPRTmi_ 
nois by selection in media supplemented with hypoxan- 
thine, aminopterin and thymidine (HAT) were also unsuc- 
cessful. This was probably due to the extremely low lev- 
els of  active HPRTIHinoi s that are produced by the trans- 
fected clones. 
Despite the absence of peptide sequence data, alterna- 
tive explanations for the partial HPRT activity observed in 
patient RT are limited. One hypothesis is that translational 
initiation in HPRTllIi~oi~ mRNA begins at a downstream 
AUG codon producing a truncated HPRT protein. How- 
ever, the Lesch-Nyhan patient HPRT1151 has a G-to-A 
transition at nucleotide +3 that alters the AUG start co- 
don to AUA (Tarl6 et al. 1991; Table 1). Presumably, 
HPRT1151 mRNA would be capable of  producing func- 
tional HPRT by translational initiation at the next in frame 
AUG codon (nucleotide +120). Analysis of  cell lysates 
obtained from HPRTH51 lymphoblasts using the in situ ac- 
tivity gel assay failed to reveal evidence for the formation 
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Table 1. HPRT mutations of the initiation codon and clinical phenotypes 
Variant Partial 5" HPRT mRNA flanking sequence a Mutation Phenotype 
HPRTNo~max CCCGCGCGCCGGCCGGCUCCGUU AUG GCG ACC Normal Normal 
HPRTminoi~ CCCGCGCGCC GUG GCG ACC Deletion -12 ~ + 1 KSS 
H P R T 1 1 s t  CCCGCGCGCCGGCCGGCUCCGUU AUA GCG ACC G3---->A LNS 
LNS, Lesch-Nyhan syndrome; KSS, Kelley-Seegmiller syndrome 
a Sequences are expressed in 5 "-3" format 
o f  a ca ta ly t ica l ly  ac t ive  t runcated HPRT prote in  (data  not  
shown).  
Ini t ia t ion at a downs t r eam in- f rame A U G  in RT is also 
not  cons is ten t  with the resul ts  repor ted  here.  I f  this were  
the case, we wou ld  expect  HPRTlllinois to be t runcated by  
40 amino  acids.  A s s u m i n g  a mean  amino  ac id  res idue 
weight  o f  113, this would  resul t  in a m i n i m u m  decrease  o f  
18,000 be tween  the t runcated HPRTminois and normal  
te t rameric  HPRT. However ,  both  HPRTnlinoi s and the na- 
t ive te t ramers  comigra te  (Figs.  2, 3). Thus our  results  indi-  
cate  that HPRTininoi s is the resul t  o f  t ransla t ion at the in- 
f rame G U G  at base  pair  1 ", the resul t  o f  a 13 bp de le t ion  
with subsequent  jux tapos i t ion  o f  a G to the remain ing  U G  
of  the normal  start codon.  
Transla t ional  ini t ia t ion at n o n - A U G  codons  is rare, but  
has been repor ted  to occur  in a var ie ty  o f  eukaryot ic  sys- 
tems (see Kozak  1991, for review;  also Curran and Ko-  
l akofsky  1988; Giorgi  at al. 1983). Often t ranslat ional  ini- 
t ia t ion at n o n - A U G  codons  occurs  in conjunct ion  with  ini- 
t ia t ion events  at A U G  codons  of  the same m R N A  such as 
has  been  desc r ibed  for  the human  f ibroblas t  growth factor  
gene (Prats et  al. 1989; F lo rk iewicz  and S o m m e r  1989). 
Precedence  also exists  for  the use o f  a l ternat ive ini t ia t ion 
codons  in genes encoding  enzymes  o f  pur ine  b iosynthe-  
sis. Taira et al. (1990) have  descr ibed  a tes tes-speci f ic  iso- 
form of  the phosphor ibosy lpy rophospha te  synthetase  
gene that exc lus ive ly  uses an A C G  codon  for  t rans la t ional  
ini t ia t ion in vitro; however ,  def ini t ive  evidence  for  the use 
o f  this  codon  in v ivo  has not  yet  been  repor ted.  
Al though  the G U G  codon that ini t iates t ransla t ion in 
HPRTillinois has not  been prev ious ly  descr ibed  in humans ,  
G U G  ini t ia t ion codon  usage  is not  unpreceden ted  in eu- 
karyotes ,  par t icular ly  in cons idera t ion  of  the context  o f  
the sur rounding sequence.  The  dele t ion in HPRTminois pro-  
duces  the sequence C G C  G C C  GUG G (Table 1). Studies  
in eukaryotes  have  shown that t ranslat ional  ini t iat ion is 
mos t  eff ic ient  when the start  codon  is in the context  G C C  
( A / G)CC AUG G (Kozak  1986, 1987). The  muta t ion  in 
HPRTnlinoi s recapi tula tes  this consensus  sequence - 4  to +1 
with  respect  to the G U G  codon.  Addi t iona l ly ,  the GC-r i ch  
downs t r eam sequences  present  in HPRT m R N A  may  con- 
tr ibute to a favorable  context  for a l ternat ive ini t ia tor  
codon  usage  in HPRTnlinoi s (Kozak  1989). Of  the six alter- 
na t ive  ini t iator  codons  ident i f ied,  G U G  is the most  effi- 
cient,  p roduc ing  up to 3 % - 5 %  of  the amount  of  protein  
p roduced  by  the usual  A U G  codon  (Kozak  1989, 1990). 
Al though  in eukaryotes  there have been  more  reports  o f  
A C G  and C U G  ini t ia t ion codon  usage,  ini t ia t ion at G U G  
has been documen ted  for Drosophila melanogaster 
chol ine  ace ty l t ransferase  m R N A  (Sugihara  et al. 1990). 
In summary,  this is the first  demons t ra t ion  of  a func- 
t ional  G U G  ini t ia t ion codon  in humans,  and interest ingly,  
the capabi l i ty  of  the G U G  codon  to dr ive  t ransla t ion has 
spared pat ient  RT severe  neuro log ica l  disease.  Because  o f  
the low levels  o f  HPRTminois p roduced  by  RT lym-  
phoblas ts ,  pur i f ica t ion and a formal  kinet ic  analysis  o f  
this mutant  prote in  was not  poss ible .  However ,  our  data  
supports  the hypothes is  that HPRTminois is ca ta ly t ica l ly  
normal ,  with the par t ia l  def ic iency  due to d imin i shed  
amounts  o f  HPRT prote in  product ion.  Presumably ,  this is 
due to ineff ic ient  t ransla t ion ini t ia t ion at the newly  
fo rmed  G U G  start codon.  
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